BioLife Solutions, Inc. Overview
Pro stress-test →BioLife Solutions develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry, with products used in basic and applied research, and commercial manufacturing of biologic-based therapies. The company addresses a critical infrastructure need in the rapidly expanding cell and gene therapy market.
Strategic Profile
Pro stress-test →BioLife specializes in biopreservation and cold chain workflow solutions, developing proprietary cryopreservation media and technology platforms designed to maintain cell viability and functionality during processing, storage and transport. Flagship offerings include CryoStor cryopreservation media, HypoThermosol hypothermic storage solution, and the ThawSTAR automated cell thawing instrument.
Competitive Landscape
Pro stress-test →BioLife competes in the specialized biopreservation and cell processing equipment market. Key competitors include larger medical device companies and specialized life science suppliers. BioLife's advantage lies in proprietary formulations and integrated cold-chain solutions tailored specifically for CGT applications.
Industry Context
BioLife Solutions, Inc. operates in Medical Devices & Bioproduction Equipment - Cell and Gene Therapy.
Key facts
Headquarters: Bothell, Washington · Market cap: $1.17B